Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia

Ann Hematol. 2017 May;96(5):881-882. doi: 10.1007/s00277-017-2957-2. Epub 2017 Feb 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Anemia, Hemolytic, Autoimmune / immunology*
  • Anemia, Hemolytic, Autoimmune / pathology
  • Anemia, Hemolytic, Autoimmune / therapy
  • Anemia, Hemolytic, Autoimmune / virology
  • Autoimmunity* / drug effects
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Cytophagocytosis* / drug effects
  • Drug Therapy, Combination
  • Erythema Infectiosum / immunology*
  • Erythema Infectiosum / pathology
  • Erythema Infectiosum / therapy
  • Erythema Infectiosum / virology
  • Erythrocytes / drug effects
  • Erythrocytes / immunology
  • Erythrocytes / pathology
  • Erythrocytes / virology
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Male
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Monocytes / pathology
  • Monocytes / virology
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Neutrophils / pathology
  • Neutrophils / virology
  • Parvovirus B19, Human / drug effects
  • Parvovirus B19, Human / immunology*
  • Rituximab / therapeutic use
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / pathology
  • Severe Combined Immunodeficiency / therapy
  • Severe Combined Immunodeficiency / virology
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Rituximab
  • Cyclophosphamide